During the past decade, Alliance for Multispecialty Research, LLC conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 9 clinical trials were completed, i.e. on average, 14.5% percent of trials that started reached the finish line to date. In the past 5 years, 56 clinical trials started and 9 clinical trials were completed. i.e. 16.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alliance for Multispecialty Research, LLC" #1 sponsor was "Pfizer" with 19 trials, followed by "ModernaTX, Inc." with 10 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored, "Janssen Vaccines & Prevention B.V." with 4 trials sponsored and "BioNTech SE" with 4 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alliance for Multispecialty Research, LLC" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "IQVIA Inc." with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Alliance for Multispecialty Research, LLC" are "Pneumococcal Disease" (5 trials), "Migraine" (4 trials), "SARS-CoV-2" (4 trials), "SARS-CoV-2 Infection" (4 trials) and "COVID-19" (3 trials). Many other conditions were trialed in "Alliance for Multispecialty Research, LLC" in a lesser frequency.

Most popular intervention types in "Alliance for Multispecialty Research, LLC" are "Biological" (37 trials), "Drug" (25 trials), "Other" (11 trials), "Behavioral" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "Saline" (5 trials), "BNT162b2" (3 trials), "MenABCWY" (3 trials) and "mRNA-1273" (3 trials). Other intervention names were less common.

The vast majority of trials in "Alliance for Multispecialty Research, LLC" are 56 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Alliance for Multispecialty Research, LLC". 1 are not yet recruiting, 12 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Alliance for Multispecialty Research, LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Alliance for Multispecialty Research, LLC, 9 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".